273 related articles for article (PubMed ID: 33568987)
1. Protective Effect of the α7 Nicotinic Receptor Agonist PNU-282987 on Dopaminergic Neurons Against 6-Hydroxydopamine, Regulating Anti-neuroinflammatory and the Immune Balance Pathways in Rat.
Jiang Y; Ma H; Wang X; Wang Z; Yang Y; Li L; Feng T
Front Aging Neurosci; 2020; 12():606927. PubMed ID: 33568987
[TBL] [Abstract][Full Text] [Related]
2. Auricular Vagus Nerve Stimulation Exerts Antiinflammatory Effects and Immune Regulatory Function in a 6-OHDA Model of Parkinson's Disease.
Jiang Y; Cao Z; Ma H; Wang G; Wang X; Wang Z; Yang Y; Zhao H; Liu G; Li L; Feng T
Neurochem Res; 2018 Nov; 43(11):2155-2164. PubMed ID: 30311182
[TBL] [Abstract][Full Text] [Related]
3. The α7 nicotinic acetylcholine receptor agonist PNU-282987 ameliorates sepsis-induced acute kidney injury through CD4+CD25+ regulatory T cells in rats.
Shi X; Li J; Han Y; Wang J; Li Q; Zheng Y; Li W
Bosn J Basic Med Sci; 2022 Oct; 22(6):882-893. PubMed ID: 35535600
[TBL] [Abstract][Full Text] [Related]
4. Short-Term High-Fat Diet Consumption Reduces Hypothalamic Expression of the Nicotinic Acetylcholine Receptor α7 Subunit (α7nAChR) and Affects the Anti-inflammatory Response in a Mouse Model of Sepsis.
Souza ACP; Souza CM; Amaral CL; Lemes SF; Santucci LF; Milanski M; Torsoni AS; Torsoni MA
Front Immunol; 2019; 10():565. PubMed ID: 30967878
[TBL] [Abstract][Full Text] [Related]
5. The α7 nAChR allosteric modulator PNU-120596 amends neuroinflammatory and motor consequences of parkinsonism in rats: Role of JAK2/NF-κB/GSk3β/ TNF-α pathway.
Gowayed MA; El-Sayed NS; Matar NA; Afify EA; El-Ganainy SO
Biomed Pharmacother; 2022 Apr; 148():112776. PubMed ID: 35272136
[TBL] [Abstract][Full Text] [Related]
6. The α7 nAChR agonist PNU-282987 reduces inflammation and MPTP-induced nigral dopaminergic cell loss in mice.
Stuckenholz V; Bacher M; Balzer-Geldsetzer M; Alvarez-Fischer D; Oertel WH; Dodel RC; Noelker C
J Parkinsons Dis; 2013; 3(2):161-72. PubMed ID: 23938346
[TBL] [Abstract][Full Text] [Related]
7. Activation of α7nAChR Protects Against Gastric Inflammation and Dysmotility in Parkinson's Disease Rats.
Zhou L; Zheng LF; Zhang XL; Wang ZY; Yao YS; Xiu XL; Liu CZ; Zhang Y; Feng XY; Zhu JX
Front Pharmacol; 2021; 12():793374. PubMed ID: 34880768
[TBL] [Abstract][Full Text] [Related]
8. Activation of α7 Nicotinic Acetylcholine Receptor Protects Against 1-Methyl-4-Phenylpyridinium-Induced Astroglial Apoptosis.
Hua Y; Yang B; Chen Q; Zhang J; Hu J; Fan Y
Front Cell Neurosci; 2019; 13():507. PubMed ID: 31780901
[TBL] [Abstract][Full Text] [Related]
9. Activation of Nicotinic Acetylcholine α7 Receptor Attenuates Progression of Monocrotaline-Induced Pulmonary Hypertension in Rats by Downregulating the NLRP3 Inflammasome.
Deng Y; Guo SL; Wei B; Gao XC; Zhou YC; Li JQ
Front Pharmacol; 2019; 10():128. PubMed ID: 30863307
[No Abstract] [Full Text] [Related]
10. α7 Nicotinic acetylcholine receptor-mediated anti-inflammatory effect in a chronic migraine rat model via the attenuation of glial cell activation.
Liu Q; Liu C; Jiang L; Li M; Long T; He W; Qin G; Chen L; Zhou J
J Pain Res; 2018; 11():1129-1140. PubMed ID: 29942148
[TBL] [Abstract][Full Text] [Related]
11. 3-[(2,4-Dimethoxy)benzylidene]-anabaseine dihydrochloride protects against 6-hydroxydopamine-induced parkinsonian neurodegeneration through α7 nicotinic acetylcholine receptor stimulation in rats.
Suzuki S; Kawamata J; Matsushita T; Matsumura A; Hisahara S; Takata K; Kitamura Y; Kem W; Shimohama S
J Neurosci Res; 2013 Mar; 91(3):462-71. PubMed ID: 23239187
[TBL] [Abstract][Full Text] [Related]
12. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
[TBL] [Abstract][Full Text] [Related]
13. JAK2/STAT3 Pathway is Required for α7nAChR-Dependent Expression of POMC and AGRP Neuropeptides in Male Mice.
Souza CM; do Amaral CL; Souza SC; de Souza ACP; de Cássia Alves Martins I; Contieri LS; Milanski M; Torsoni AS; Ignacio-Souza LM; Torsoni MA
Cell Physiol Biochem; 2019; 53(4):701-712. PubMed ID: 31592599
[TBL] [Abstract][Full Text] [Related]
14. Involvement of astroglial fibroblast growth factor-2 and microglia in the nigral 6-OHDA parkinsonism and a possible role of glucocorticoid hormone on the glial mediated local trophism and wound repair.
Silva C; Fuxe K; Chadi G
J Neural Transm Suppl; 2009; (73):185-202. PubMed ID: 20411778
[TBL] [Abstract][Full Text] [Related]
15. Acute lung injury is reduced by the α7nAChR agonist PNU-282987 through changes in the macrophage profile.
Pinheiro NM; Santana FP; Almeida RR; Guerreiro M; Martins MA; Caperuto LC; Câmara NO; Wensing LA; Prado VF; Tibério IF; Prado MA; Prado CM
FASEB J; 2017 Jan; 31(1):320-332. PubMed ID: 27729414
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of glycogen synthase kinase-3β by lithium chloride suppresses 6-hydroxydopamine-induced inflammatory response in primary cultured astrocytes.
Wang HM; Zhang T; Li Q; Huang JK; Chen RF; Sun XJ
Neurochem Int; 2013 Nov; 63(5):345-53. PubMed ID: 23871716
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective Effect of Optimized Yinxieling Formula in 6-OHDA-Induced Chronic Model of Parkinson's Disease through the Inflammation Pathway.
Wei R; Rong C; Xie Q; Wu S; Feng Y; Wang R; Dai Z; Lin T
Evid Based Complement Alternat Med; 2019; 2019():2529641. PubMed ID: 31929812
[TBL] [Abstract][Full Text] [Related]
18. 6-hydroxydopamine lesion of rat nigrostriatal dopaminergic neurons differentially affects nicotinic acetylcholine receptor subunit mRNA expression.
Elliott KJ; Jones JM; Sacaan AI; Lloyd GK; Corey-Naeve J
J Mol Neurosci; 1998 Jun; 10(3):251-60. PubMed ID: 9770646
[TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
Lee EY; Lee JE; Park JH; Shin IC; Koh HC
Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
[TBL] [Abstract][Full Text] [Related]
20. Altered melatonin MT
Kang NH; Carriere CH; Bahna SG; Niles LP
Brain Res; 2016 Dec; 1652():89-96. PubMed ID: 27693415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
